Bcl 2 Like Protein 1 (Apoptosis Regulator BclX or BCLX or BCL2L1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Published	Pages	Publisher	Report code
Nov 2022	71	Global Markets Direct	ASDR-613184

Published: Nov 2022 - Pages : 71 - Publisher : Global Markets Direct - Report code : ASDR-613184

AbbVie Inc
Ascenta Therapeutics Inc
Ascentage Pharma Group International
AstraZeneca Plc
Dialectic Therapeutics Inc
Sirnaomics Ltd
Zentalis Pharmaceuticals Inc

Bcl 2 Like Protein 1 - Pipeline Review, H1 2020

This report can be of interest as well:

Bcl 2 Like Protein 1 - Pipeline Review, H1 2020

Published: June, 2020 | Report code: ASDR-544462